Related Experiment Videos
L-Selectin--a signalling receptor for lipopolysaccharide
1Glycobiology Research Unit, Cellular Science Division, Glaxo-Wellcome Medicines Research Centre, Gunnel's Wood Road, Stevenage, Herts, SG1 2NY, UK. rm 18326@ggr.co.uk
Chemistry & Biology
|August 1, 1997
Summary
Lipopolysaccharide activates leukocytes, contributing to septic shock. L-selectin may act as a lipopolysaccharide receptor in neutrophils, suggesting L-selectin inhibitors could treat this condition.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Leukocyte activation by bacterial lipopolysaccharide (LPS) is a key factor in septic shock development.
- Septic shock is a life-threatening condition with significant mortality.
- Understanding the molecular mechanisms of leukocyte activation is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of L-selectin as a potential receptor for lipopolysaccharide (LPS) on neutrophils.
- To explore the therapeutic potential of targeting L-selectin in the context of LPS-induced leukocyte activation and septic shock.
Main Methods:
- The study proposes a novel hypothesis regarding L-selectin function.
- The research likely involves in vitro assays to assess L-selectin binding to LPS and its downstream effects on neutrophils.
- Further investigations may include cellular signaling pathway analysis and potentially in vivo models.
Main Results:
- The abstract suggests that L-selectin functions as a low-affinity receptor for LPS on neutrophils.
- This interaction is proposed to contribute to leukocyte activation in the context of bacterial infections.
Conclusions:
- L-selectin's role as an LPS receptor offers a new perspective on leukocyte activation in sepsis.
- Inhibitors targeting L-selectin may represent a promising therapeutic strategy for managing septic shock.